SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-20-009005
Filing Date
2020-04-30
Accepted
2020-04-30 16:07:40
Documents
2
Period of Report
2019-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 3/A rdgdoc.html 3/A  
1 FORM 3/A rdgdoc.xml 3/A 2481
2 davispoa.htm EX-24 6579
  Complete submission text file 0001437749-20-009005.txt   10739
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address
Davis Todd C (Reporting) CIK: 0001392029 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-35285 | Film No.: 20835690